Previous 10 | Next 10 |
HLS Therapeutics said it signed product listing agreements (PLA) with New Brunswick, Northwest Territories and the Non-Insured Health Benefits (NIHB) for First Nations and Inuit peoples, for public reimbursement of heart drug Vascepa on their respective public prescription drug insurance...
Sarissa intends to "Abstain" given ongoing engagement with Amarin to add shareholder representatives to the board Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin Corporation plc (NASDAQ: AMRN) regarding how it intends to v...
The shares of commercial stage biotech Amarin Corporation (NASDAQ:AMRN) gained in the pre-market Friday after the company announced positive recommendation in the U.K. for reimbursement of heart disease therapy Vazkepa (icosapent ethyl). UK’s National Institute for Health and Care Exce...
UK’s NICE issued its draft Final Appraisal Document (FAD) recommending the use of VAZKEPA ® (icosapent ethyl) in England and Wales to reduce the risk of cardiovascular (CV) events in adult statin-treated patients at high CV risk who have elevated triglycerides (≥150...
Amarin Corporation plc 2022 Jefferies Global Healthcare Conference Call June 8, 2022 1:00 P.M. ET Company Participants Karim Mikhail - President and Chief Executive Officer Conference Call Participants Michael Yee - Jefferies Presentation Michael Yee Thank you. Well, good afternoon, everyone,...
Penny stocks are great tools to make money in the stock market. While they don’t come without risk, there are plenty of ways to ensure you find the top names to watch. One of the first steps is looking for specific catalysts. These could be anything from unusual trading activity to m...
Amarin Corp. (NASDAQ:AMRN) will undertake an organizational restructuring plan in an effort to save $100M over the next year. Shares are up 8% in premarket trading. This will result in a 90% reduction of its U.S. commercial team based on where it was before the pandemic and introduc...
-- Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12 Months* While Continuing to Invest in European Launches and Global Expansion -- -- Reduces U.S. Commercial Organization by Ninety Percent of Pre-Pandemic / Pre-Generic Competition Levels --...
Amarin Corporation (NASDAQ:AMRN) has appointed Tom Reilly as Chief Financial Officer, effective June 20, 2022, following the resignation of Michael W. Kalb. Michael is stepping down to pursue other interests. Most recently, Tom Reilly served as Chief Financial Officer for Cara Thera...
-- Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin -- -- Michael W. Kalb to Depart Amarin to Pursue Other Interests -- DUBLIN, Ireland and BRIDGEWATER, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) t...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...